Expertise in Long-Chain Monomer Synthesis
We specialize in engineering pathways for C3, C4, and C6 monomers (PDO, BDO, HMDA), crucial for high-performance polyurethane synthesis.
Polyurethanes are versatile polymers used in foams, coatings, and elastomers. Their conventional production relies on petrochemical precursors, notably toxic isocyanates and fossil-derived polyols. The industry is facing increasing pressure to transition to safer, sustainable, and bio-based alternatives, such as bio-diols, bio-diamines, and Non-Isocyanate Polyurethane (NIPU) routes.
CD Biosynsis focuses on engineering high-performance microbial cell factories for the synthesis of key bio-precursors, including 1,4-Butanediol (Bio-BDO), 1,3-Propanediol (Bio-PDO), and Hexamethylenediamine (Bio-HMDA). We utilize synthetic biology and metabolic engineering to optimize novel pathways in microbial hosts, enabling the industrial production of sustainable building blocks for next-generation, environmentally friendly polyurethanes.
Get a QuoteDeveloping bio-based precursors for sustainable polyurethanes faces several critical metabolic and process limitations:
Overcoming these challenges requires comprehensive metabolic reprogramming to efficiently channel carbon flux from renewable feedstocks to these specific high-value monomers.
CD Biosynsis applies advanced synthetic biology and metabolic engineering to enhance the sustainable production of polyurethane precursors:
Biosynthesis of Bio-BDO and Bio-PDO
We optimize central carbon metabolism and terminal reductase enzymes for high carbon yield and titer of key diol precursors, such as 1,4-Butanediol (BDO) and 1,3-Propanediol (PDO).
Metabolic Engineering for Bio-HMDA
We design and balance multi-step non-natural pathways (e.g., from Lysine) and engineer key aminotransferase and reductase enzymes for efficient biosynthesis of Hexamethylenediamine (HMDA).
Cofactor and Pathway Balance
We engineer native and heterologous pathways to improve the intracellular supply and regeneration of cofactors (NADH/NADPH) to enhance the flux of reductive synthesis steps.
NIPU Precursor Synthesis
We develop strains for the biosynthesis of bio-based cyclic carbonates, enabling the safer and non-toxic synthesis route for Non-Isocyanate Urethanes (NIPU).
This multi-target engineering approach accelerates the realization of high-performance, bio-based polyurethane materials.
Choosing CD Biosynsis's Polyurethane Precursor strain engineering service offers the following core value:
Expertise in Long-Chain Monomer Synthesis
We specialize in engineering pathways for C3, C4, and C6 monomers (PDO, BDO, HMDA), crucial for high-performance polyurethane synthesis.
High Productivity and Scalability
Our engineered strains achieve competitive titer and yield using low-cost renewable feedstocks, ensuring economic viability for industrial scale-up.
Sustainable and Toxic-Free Solution
The bio-based approach reduces reliance on fossil fuels and supports the NIPU route, eliminating the use of toxic isocyanates.
Optimized Cofactor Management
Genetic modifications ensure sufficient energy and reducing power supply (NADH/NADPH) to maximize the flux through reductive pathways.
Accelerated Material R&D
We provide high-purity, bio-based monomers essential for validating new sustainable polyurethane formulations.
We are dedicated to providing genetically superior microbial strains to drive the commercial success of the bio-based polymer industry.
CD Biosynsis's Polyurethane Precursor strain engineering service follows a standardized research workflow, ensuring every step is precise and controllable:
Technical communication is maintained throughout the process, focusing on timely performance feedback and strategic adjustments to the metabolic engineering plan.
Accelerate your Bio-based Precursor R&D and scale-up! CD Biosynsis provides customized strain engineering solutions:
What is the advantage of NIPU over traditional polyurethane?
NIPU (Non-Isocyanate Polyurethane) is synthesized without the use of toxic isocyanates, making the manufacturing process safer and more environmentally friendly. Our solutions support the bio-based cyclic carbonate route for NIPU synthesis.
What kind of bio-based precursors can you engineer?
We focus on critical polyurethane precursors, including diols (such as 1,4-Butanediol and 1,3-Propanediol) and diamines (such as Hexamethylenediamine), which form the soft and hard segments of the polymer.
How do you deal with cofactor imbalance in reductive pathways?
We employ metabolic engineering to co-express balanced enzymatic cascades, introduce NAD/NADH or NADP/NADPH regenerating enzymes, or modify central metabolism to increase the pool of reducing power available for the synthesis pathway.
How do you ensure the precursor is suitable for polymerization?
We monitor and optimize precursor purity using advanced analytical techniques (GC/HPLC). High purity is critical, and we use genetic strategies to eliminate the formation of contaminants that could interfere with the downstream polymerization reaction.
What is the estimated project timeline for a new precursor?
The timeline varies based on pathway complexity (diol vs. diamine). A complete project, including FBA, pathway editing, enzyme optimization, and fermentation validation, typically requires 18-24 weeks.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.